Contents
Issue 123 • October 2022
In association with
In association with
Comment
The potential of virtual reality-based therapy for serious mental disorders
Brazil: an untapped market for big pharma manufacturing
More big wins for the AstraZeneca-Daiichi Sankyo collaboration
Dry powder inhalers carry potential to decrease greenhouse gas emissions
Black participants severely underrepresented in global oncology studies
Polio outbreak in New York state due to low vaccination coverage
In Depth
Exploring the promise of billion-dollar KRAS drugs
Nanorobots: small solutions to big delivery problems
Foreign investments amplify the nucleic acid therapeutics field
Going beyond the mirage of complete skin clearance in psoriasis
As Russia’s clinical trials sector falls, Ukraine rebuilds
CMO Moves: Regulatory catalysts for drug manufacturing- September
Comment
Brazil: an untapped market for big pharma manufacturing